Presentation EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Presenter: Jeff Weitz March 20, 2017 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Prevention Presentation ACC 2017 Up Next Presentation Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017 More slides + Presentation iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017 Presentation Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017 We Recommend
Presentation Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017
Presentation iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017
Presentation Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR) Presenter: Michael Mack March 20, 2017